Key financial ranges
Market cap · USD equivalent
P/E ratio
Annual revenue · USD equivalent
Revenue growth
Valuation & profitability
Price / sales
Annual net income · USD equivalent
Net profit margin
Cash & debt
Cash · USD equivalent
Total debt · USD equivalent
Net cash · USD equivalent
Debt / revenue
| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| SPHSuburban Propane Partners Lp | $1.17B | 9.0× | $1.43B | +7.9% | $106.57M | $5.03M | $1.33B | Fair valued |
| KURAKura Oncology, Inc. | $1.16B | — | $67.48M | +25.2% | -$278.67M | $70.24M | $24.46M | Fair valued |
| DEAEasterly Government Properties, Inc. | $1.16B | 118.2× | $336.1M | +11.3% | $13M | $3.3M | $1.71B | Undervalued |
| OCSLOaktree Specialty Lending Corp | $1.16B | 27.4× | $316.8M | -17.0% | $33.92M | $39.92M | $1.44B | Undervalued |
| PSECProspect Capital Corp | $1.16B | 126.0× | $639.45M | -11.1% | $153.66M | $43.57M | $1.86B | Undervalued |
| TUYATuya Inc. | $1.16B | 17.0× | $321.79M | +7.8% | $57.89M | $890.71M | $5.31M | Undervalued |
| GIIIG Iii Apparel Group Ltd | $1.16B | 9.0× | $2.96B | -7.0% | $67.35M | $394.22M | $282.52M | Fair valued |
| SANASana Biotechnology, Inc. | $1.16B | — | — | — | — | $57.07M | $73.74M | Fair valued |
| WINAWinmark Corp | $1.15B | 29.2× | $86.06M | +5.9% | $41.65M | $25.83M | $2.76M | Overvalued |
| AMTBAmerant Bancorp Inc. | $1.15B | 21.1× | $439.3M | +30.8% | $52.42M | $301.13M | $115.31M | Fair valued |
| HZOMarinemax Inc | $1.15B | 361.3× | $2.31B | -5.0% | -$31.63M | $174.78M | $1.11B | Fair valued |
| MCBMetropolitan Bank Holding Corp. | $1.15B | 11.8× | $315.11M | +13.8% | $71.1M | $239.26M | $49.34M | Fair valued |
| FSBCFive Star Bancorp | $1.15B | 13.9× | $158.44M | +25.6% | $61.61M | $685.07M | $11.26M | Fair valued |
| PDSPRECISION DRILLING Corp | $1.15B | — | CA$1.84B | -3.1% | CA$3.09M | CA$85.78M | CA$751.8M | Fair valued |
| CPACCementos Pacasmayo Saa | $1.15B | 17.6× | PEN 1.98B | +1.4% | PEN 198.88M | PEN 72.72M | PEN 9.42M | Fair valued |
| TDOCTeladoc Health, Inc. | $1.15B | — | $2.53B | -1.5% | -$200.32M | $774.35M | $39.51M | Fair valued |
| UVVUniversal Corp | $1.14B | 61.1× | $2.89B | -1.3% | $32.64M | $173.59M | $1.22B | Fair valued |
| IGICInternational General Insurance Holdings Ltd. | $1.13B | 10.7× | $516.88M | -4.1% | $127.15M | $186.18M | $1.56M | Fair valued |
| IVAInventiva S.A. | $1.13B | — | €9.2M | -47.4% | -€184.21M | €122.08M | €4.03M | Fair valued |
| GSBDGoldman Sachs BDC, Inc. | $1.13B | 19.4× | — | — | — | $14.43M | $1.85B | Fair valued |